Interstitial pericytes decrease in aged mouse kidneys

Aging

Volumn 7, Issue 6, 2015, Pages 370-382

  Stefanska, Ania ^a   Eng, Diana ^a   Kaverina, Natalya ^a   Duffield, Jeremy S ^a,c   Pippin, Jeffrey W ^a   Rabinovitch, Peter ^b   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BIOGEN   (United States)

Author keywords

Endothelium; Nephropathy; NG2; PDGF receptor; Tubulo interstitial fibrosis

Indexed keywords

ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEOGLYCAN;

AGING; ANATOMY AND HISTOLOGY; ANIMAL; C57BL MOUSE; CAPILLARY; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY FAILURE; METABOLISM; MOUSE; PERICYTE; PHYSIOLOGY; VASCULARIZATION;

AGING; ANIMALS; ANTIGENS; CAPILLARIES; FEMALE; GENE EXPRESSION REGULATION; KIDNEY; MICE; MICE, INBRED C57BL; PERICYTES; PROTEOGLYCANS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RENAL INSUFFICIENCY;

EID: 84935461172     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100756     Document Type: Article

References (73)

1. Brown WW, Abrass IB and Oreopoulos DG. Introduction: aging and the kidney. Advances in renal replacement therapy. 2000;7:1-3.
2. Glassock RJ and Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 2012; 82:270-277.
3. Abrass CK. The nature of chronic progressive nephropathy in aging rats. Advances in renal replacement therapy. 2000; 7:4-10.
4. Abdel-Rahman EM and Okusa MD. Effects of aging on renal function and regenerative capacity. Nephron Clinical practice. 2014; 127:15-20.
5. Schmitt R and Cantley LG. The impact of aging on kidney repair. American journal of physiology Renal physiology. 2008;294:F1265-1272.
6. Wang X, Bonventre JV and Parrish AR. The aging kidney: increased susceptibility to nephrotoxicity. International journal of molecular sciences. 2014; 15:15358-15376.
7. Long DA, Mu W, Price KL and Johnson RJ. Blood vessels and the aging kidney. Nephron Experimental nephrology. 2005;101:e95-99.
8. Scioli MG, Bielli A, Arcuri G, Ferlosio A and Orlandi A. Ageing and microvasculature. Vascular cell. 2014; 6:19.
9. Lahteenvuo J and Rosenzweig A. Effects of aging on angiogenesis. Circulation research. 2012; 110:1252-1264.
10. Weinstein JR and Anderson S. The aging kidney: physiological changes. Advances in chronic kidney disease. 2010; 17:302-307.
11. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ and Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol. 1998; 9:231-242.
12. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF and Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2001; 37:601-611.
13. Kwon O, Hong SM, Sutton TA and Temm CJ. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. American journal of physiology Renal physiology. 2008; 295:F351-359.
14. Tanaka T, Kato H, Kojima I, Ohse T, Son D, Tawakami T, Yatagawa T, Inagi R, Fujita T and Nangaku M. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. The journals of gerontology Series A, Biological sciences and medical sciences. 2006; 61:795-805.
15. Bergers G and Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncology. 2005; 7:452-464.
16. Ren S and Duffield JS. Pericytes in kidney fibrosis. Current opinion in nephrology and hypertension. 2013; 22:471-480.
17. Diaz-Flores L, Gutierrez R, Varela H, Rancel N and Valladares F. Microvascular pericytes: a review of their morphological and functional characteristics. Histology and histopathology. 1991;6:269-286.
18. Armulik A, Genove G and Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Developmental cell. 2011; 21:193-215.
19. Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014; 124:2299-2306.
20. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell stem cell. 2008; 3:301-313.
21. Covas DT, Panepucci RA, Fontes AM, Silva WA, Jr., Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC and Zago MA. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and geneexpression profile with CD146+ perivascular cells and fibroblasts. Experimental hematology. 2008; 36:642-654.
22. Hirschi KK, Rohovsky SA and D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. The Journal of cell biology. 1998; 141:805-814.
23. Kim YM, Jeon ES, Kim MR, Jho SK, Ryu SW and Kim JH. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. The international journal of biochemistry&cell biology. 2008;40:2482-2491.
24. Armulik A, Abramsson A and Betsholtz C. Endothelial/pericyte interactions. Circulation research. 2005;97:512-523.
25. Crawford C, Kennedy-Lydon T, Sprott C, Desai T, Sawbridge L, Munday J, Unwin RJ, Wildman SS and Peppiatt-Wildman CM. An intact kidney slice model to investigate vasa recta properties and function in situ. Nephron Physiology. 2012; 120:p17-31.
26. Pallone TL and Silldorff EP. Pericyte regulation of renal medullary blood flow. Experimental nephrology. 2001; 9:165-170.
27. Dar A, Domev H, Ben-Yosef O, Tzukerman M, Zeevi-Levin N, Novak A, Germanguz I, Amit M and Itskovitz-Eldor J. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation. 2012;125:87-99.
28. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP and Duffield JS. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010; 176:85-97.
29. Lin SL, Kisseleva T, Brenner DA and Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagenproducing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008; 173:1617-1627.
30. Schrimpf C, Teebken OE, Wilhelmi M and Duffield JS. The role of pericyte detachment in vascular rarefaction. Journal of vascular research. 2014; 51:247-258.
31. Junqueira LC, Bignolas G and Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. The Histochemical journal. 1979;11:447-455.
32. Montes GS and Junqueira LC. The use of the Picrosiriuspolarization method for the study of the biopathology of collagen. Mem Inst Oswaldo Cruz. 1991; 86 Suppl 3:1-11.
33. Smith SW, Chand S and Savage CO. Biology of the renal pericyte. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2012; 27:2149-2155.
34. Kennedy-Lydon TM, Crawford C, Wildman SS and Peppiatt-Wildman CM. Renal pericytes: regulators of medullary blood flow. Acta physiologica. 2013; 207:212-225.
35. Berg AC, Chernavvsky-Sequeira C, Lindsey J, Gomez RA and Sequeira-Lopez ML. Pericytes synthesize renin. World journal of nephrology. 2013; 2:11-16.
36. Strutz F and Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. Journal of the American Society of Nephrology: JASN. 2006; 17:2992-2998.
37. Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M and Deutsch U. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes. 2004; 53:1104-1110.
38. Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, Teng Y, Duncan MB, Xie L, Maeda G, Vong S, Sugimoto H, Rocha RM, Damascena A, et al. Pericyte depletion results in hypoxiaassociated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer cell. 2012; 21:66-81.
39. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A and Zlokovic BV. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nature communications. 2013;4:2932.
40. Geevarghese A and Herman IM. Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Translational research: the journal of laboratory and clinical medicine. 2014; 163:296-306.
41. Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel PL, Molitoris BA, Murthy M, O'Hare AM, Schmader KE and High KP. Acute kidney injury in older adults. Journal of the American Society of Nephrology: JASN. 2011;22:28-38.
42. Pippin JW, Glenn ST, Krofft RD, Rusiniak ME, Alpers CE, Hudkins K, Duffield JS, Gross KW and Shankland SJ. Cells of renin lineage take on a podocyte phenotype in aging nephropathy. American journal of physiology Renal physiology. 2014;306:F1198-1209.
43. Flurkey K CJ, Harrison DE. 2006. Mouse Models in Aging Research. In: The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models.: Burlington: Academic Press (Elsevier).
44. http://www.nia.nih.gov/research/dab/aged-rodent-colonieshandbook/strain-survival-information. 2015. National Institute on Aging. Aged Rodent Colonies Handbook: Strain Survival Information.
45. Nadon NL. Exploiting the rodent model for studies on the pharmacology of lifespan extension. Aging Cell. 2006; 5:9-15.
46. Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD and Hart RW. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci. 1999; 54:B492-501.
47. Bolignano D, Mattace-Raso F, Sijbrands EJ and Zoccali C. The aging kidney revisited: a systematic review. Ageing Res Rev. 2014; 14:65-80.
48. Lim JH, Kim EN, Kim MY, Chung S, Shin SJ, Kim HW, Yang CW, Kim YS, Chang YS, Park CW and Choi BS. Age-associated molecular changes in the kidney in aged mice. Oxid Med Cell Longev. 2012; 2012:171383.
49. Stefanska A, Peault B and Mullins JJ. Renal pericytes: multifunctional cells of the kidneys. Pflugers Archiv: European journal of physiology. 2013; 465:767-773.
50. Nakagawa N, Xin C, Roach AM, Naiman N, Shankland SJ, Ligresti G, Ren S, Szak S, Gomez IG, Duffield JS. Dicer1 activity in the stromal compartment regulates nephron differentiation and vascular patterning during mammalian kidney organogenesis. Kidney international. 4 February 2015;[Epub ahead of print]
51. Lindahl P, Johansson BR, Leveen P and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277:242-245.
52. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA and Iadecola C. A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol. 2001; 281:H2417-2424.
53. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M and Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014; 508:55-60.
54. Hayden MR, Yang Y, Habibi J, Bagree SV and Sowers JR. Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes. Oxid Med Cell Longev. 2010; 3:290-303.
55. Hamilton NB, Attwell D and Hall CN. Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics. 2010; 2.
56. Kawakami T, Mimura I, Shoji K, Tanaka T and Nangaku M. Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes. Kidney international supplements. 2014; 4:107-112.
57. Kida Y, Tchao BN and Yamaguchi I. Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatric nephrology. 2014; 29:333-342.
58. Jones DL and Rando TA. Emerging models and paradigms for stem cell ageing. Nature cell biology. 2011; 13:506-512.
59. Liu L and Rando TA. Manifestations and mechanisms of stem cell aging. The Journal of cell biology. 2011; 193:257-266.
60. Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, Henderson JM, Ebert BL and Humphreys BD. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell stem cell. 2015; 16:51-66.
61. Jasper H and Kennedy BK. Niche science: the aging stem cell. Cell cycle. 2012; 11:2959-2960.
62. Font de Mora J and Diez Juan A. The decay of stem cell nourishment at the niche. Rejuvenation research. 2013; 16:487-494.
63. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND and Silva FG. The aging kidney. Kidney international. 2008; 74:710-720.
64. Boor P and Floege J. The renal (myo-)fibroblast: a heterogeneous group of cells. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2012;27:3027-3036.
65. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H and Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nature medicine. 2013; 19:1047-1053.
66. Chen YT, Chang FC, Wu CF, Chou YH, Hsu HL, Chiang WC, Shen J, Chen YM, Wu KD, Tsai TJ, Duffield JS and Lin SL. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 2011; 80:1170-1181.
67. Ren S, Johnson BG, Kida Y, Ip C, Davidson KC, Lin SL, Kobayashi A, Lang RA, Hadjantonakis AK, Moon RT and Duffield JS. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A. 2013; 110:1440-1445.
68. Marshall CB, Krofft RD, Pippin JW and Shankland SJ. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol Renal Physiol. 2010;298:F1140-1151.
69. Hudkins KL, Pichaiwong W, Wietecha T, Kowalewska J, Banas MC, Spencer MW, Muhlfeld A, Koelling M, Pippin JW, Shankland SJ, Askari B, Rabaglia ME, Keller MP, et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. Journal of the American Society of Nephrology: JASN. 2010; 21:1533-1542.
70. Zhang J, Yanez D, Floege A, Lichtnekert J, Krofft RD, Liu ZH, Pippin JW and Shankland SJ. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. Journal of the renin-angiotensin-aldosterone system: JRAAS. 20 August 2014; [Epub ahead of print].
71. Pichaiwong W, Hudkins KL, Wietecha T, Nguyen TQ, Tachaudomdach C, Li W, Askari B, Kobayashi T, O'Brien KD, Pippin JW, Shankland SJ and Alpers CE. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. Journal of the American Society of Nephrology : JASN. 2013; 24:1088-1102.
72. Park F, Mattson DL, Roberts LA and Cowley AW, Jr. Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla. The American journal of physiology. 1997;273:R1742-1748.
73. Hinz B. The myofibroblast: paradigm for a mechanically active cell. Journal of biomechanics. 2010; 43:146-155.